Combined Treatment with Octreotide, Galanin and Serotonin in Gastrointestinal Malignancies

Publisher： Bentham Science Publishers

E-ISSN： 1875-628x|2|6|439-443

ISSN： 1570-1808

Source： Letters in Drug Design & Discovery, Vol.2, Iss.6, 2005-09, pp. : 439-443

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Triple Treatment with Octreotide, Galanin and Serotonin is a Promising Therapy for Colorectal Cancer

By  

Current Pharmaceutical Design, Vol. 11, Iss. 16, 2005-06 ,pp. : 2107-2117

Bentham Science Publishers

Access to resources Recommend Favorite

Octreotide for acromegaly treatment: a reappraisal

By Giustina Andrea   Karamouzis Ioannis   Patelli Ilaria   Mazziotti Gherardo  

Expert Opinion on Pharmacotherapy, Vol. 14, Iss. 17, 2013-12 ,pp. : 2433-2447

Informa Healthcare

Access to resources Recommend Favorite

Serotonin pharmacology in the gastrointestinal tract: a review

By Beattie D.  

Naunyn-Schmiedeberg's Archives of Pharmacology, Vol. 377, Iss. 3, 2008-05 ,pp. : 181-203

Springer Publishing Company

Access to resources Recommend Favorite

TNF-Related Apoptosis-Inducing Ligand (TRAIL): A Potential Candidate for Combined Treatment of Hematological Malignancies

By  

Current Pharmaceutical Design, Vol. 10, Iss. 29, 2004-11 ,pp. : 3673-3681

Bentham Science Publishers

Access to resources Recommend Favorite

A Combined Approach with Rituximab Plus Anti-TRAIL-R Agonistic Antibodies for the Treatment of Haematological Malignancies

By  

Current Pharmaceutical Design, Vol. 14, Iss. 21, 2008-07 ,pp. : 2085-2099

Bentham Science Publishers

Access to resources Recommend Favorite